Speaker

Elena Viboch

General Catalyst

Elena Viboch is a Partner at General Catalyst, where she focuses on investing in life sciences. Her investments include ArriVent Biopharma, Dewpoint Therapeutics, Eikon Therapeutics, Faro Health, Maze Therapeutics, Odyssey Therapeutics, Variant Bio and Vevo Therapeutics, and she serves on the boards of CTRL Therapeutics, Faro Health and Paradigm. Prior to joining General Catalyst, Elena served as an Investment Director at SoftBank, where she helped build SoftBank Vision Fund’s healthcare portfolio, driving investments in companies such as Devoted Health and Vividion Therapeutics and serving on multiple

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved